NYSE$ANVS

Annovis Bio · Q2 2022 earnings

Q2 2022 earnings · · Investor relations

Headline financials

Total Revenue

$0.00

Previous: $0.00
EPS (adj)

-$1.07

Previous: -$0.34-214.7%
Free Cash Flow

-$8.72M

Previous: -$2.52M-245.3%
Net Income

-$8.72M

Previous: -$2.52M-245.3%
Operating Income

-$8.75M

Previous: -$2.53M-245.4%
Cash & Equivalents

$36M

Previous: $49.2M-26.9%
Total Assets

$40M

Previous: $49.5M-19.3%
Stock-Based Comp

$1.9M

Previous: $7.99K+23720.8%

Revenue & EPS history

Annovis Bio · Revenue · Quarterly

$0

Q2 2022

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q2 2022

Historical avgQ2 2022

-1.9%

Avg return

Earnings day

+0.2%

Avg return

5 days after

+9.0%

Avg return

30 days after

35%

9 / 26 earnings

Positive

+41.0%

Q1 2024

Best reaction

-68.5%

Q2 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-5.1%-7.0%
Q4 2025-3.1%-8.1%-37.1%
Q3 2025+15.5%+43.6%+95.7%
Q2 2025-1.4%-2.8%-15.2%
Q1 2025+6.6%+18.9%+66.3%
Q4 2024-7.1%-8.5%+14.2%
Q3 2024-7.6%-16.2%-27.0%
Q2 2024+9.9%+14.9%+3.2%
Q1 2024+41.0%+40.1%+2.5%
Q4 2023-6.1%-6.7%-48.7%
Q3 2023-0.3%+3.1%+76.9%
Q2 2023-1.7%-3.5%-17.0%
Q1 2023-5.8%-8.5%-9.1%
Q4 2022-22.5%-18.2%-4.9%
Q3 2022-4.1%+1.1%-3.3%
Q2 2022+5.9%+10.1%-7.1%
Q1 2022+9.9%-3.3%-1.3%
Q4 2021-7.6%-13.5%+1.0%
Q3 2021-0.9%+21.3%-30.4%
Q2 2021-68.5%-65.8%-66.2%
Q1 2021+5.8%+30.1%+188.3%
Q4 2020-10.3%-9.7%-0.5%
Q3 2020+3.8%-1.1%+28.7%
Q2 2020-0.3%-2.2%-20.6%
Q1 2020-0.8%-3.0%+21.9%
Q4 2019+6.5%+0.9%+14.1%
Q2 2019
Q1 2019
Q4 2018
Q3 2018
Q2 2018
Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro